tradingkey.logo

IDEXX Laboratories Inc

IDXX
639.790USD
-4.820-0.75%
收盤 02/09, 16:00美東報價延遲15分鐘
70.45B總市值
48.57本益比TTM

IDEXX Laboratories Inc

639.790
-4.820-0.75%

關於 IDEXX Laboratories Inc 公司

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.

IDEXX Laboratories Inc簡介

公司代碼IDXX
公司名稱IDEXX Laboratories Inc
上市日期Jun 21, 1991
CEOEmerson (Andrew)
員工數量11000
證券類型Ordinary Share
年結日Jun 21
公司地址One Idexx Drive
城市WESTBROOK
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編04092-2041
電話12075560300
網址https://www.idexx.com/
公司代碼IDXX
上市日期Jun 21, 1991
CEOEmerson (Andrew)

IDEXX Laboratories Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.69K
+262.00%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.23K
+346.00%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
7.70K
--
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
6.12K
+183.00%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
3.84K
+1447.00%
Mr. Daniel M. (Dan) Junius
Mr. Daniel M. (Dan) Junius
Independent Director
Independent Director
3.00K
+262.00%
Mr. Michael Schreck
Mr. Michael Schreck
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
1.92K
+1018.00%
Mr. Bruce L. Claflin
Mr. Bruce L. Claflin
Independent Director
Independent Director
1.72K
--
Ms. Irene Chang Britt
Ms. Irene Chang Britt
Independent Director
Independent Director
208.00
--
Mr. George J. Fennell
Mr. George J. Fennell
Executive Vice President - Global CAG Commercial
Executive Vice President - Global CAG Commercial
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.69K
+262.00%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.23K
+346.00%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
7.70K
--
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
6.12K
+183.00%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
3.84K
+1447.00%
Mr. Daniel M. (Dan) Junius
Mr. Daniel M. (Dan) Junius
Independent Director
Independent Director
3.00K
+262.00%

收入明細

單位: USD更新時間: 1月6日 週二
單位: USD更新時間: 1月6日 週二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
CAG Diagnostics recurring revenue
873.27M
79.01%
IDEXX VetLab consumables
387.81M
35.09%
Reference laboratory diagnostic and consulting services
362.73M
32.82%
Rapid assay products
88.64M
8.02%
CAG Diagnostics capital - instruments
87.78M
7.94%
其他
-694.99M
-62.88%
地區USD
名稱
營收
佔比
United States
705.04M
63.79%
Europe & Middle East & Africa (EMEA) (Region)
245.06M
22.17%
Asia Pacific
90.72M
8.21%
Canada
41.38M
3.74%
Latin America
23.04M
2.08%
業務
地區
業務USD
名稱
營收
佔比
CAG Diagnostics recurring revenue
873.27M
79.01%
IDEXX VetLab consumables
387.81M
35.09%
Reference laboratory diagnostic and consulting services
362.73M
32.82%
Rapid assay products
88.64M
8.02%
CAG Diagnostics capital - instruments
87.78M
7.94%
其他
-694.99M
-62.88%

股東統計

更新時間: 2月6日 週五
更新時間: 2月6日 週五
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
12.41%
Elyxium Wealth, LLC
6.79%
BlackRock Institutional Trust Company, N.A.
6.56%
State Street Investment Management (US)
4.41%
Fundsmith LLP
3.27%
其他
66.57%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
12.41%
Elyxium Wealth, LLC
6.79%
BlackRock Institutional Trust Company, N.A.
6.56%
State Street Investment Management (US)
4.41%
Fundsmith LLP
3.27%
其他
66.57%
股東類型
持股股東
佔比
Investment Advisor
60.50%
Investment Advisor/Hedge Fund
30.61%
Research Firm
3.98%
Pension Fund
3.21%
Bank and Trust
1.89%
Individual Investor
0.69%
Sovereign Wealth Fund
0.59%
Hedge Fund
0.50%
Family Office
0.45%

機構持股

更新時間: 1月1日 週四
更新時間: 1月1日 週四
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
2411
81.21M
101.70%
-691.60K
2025Q3
2319
77.76M
97.19%
-4.03M
2025Q2
2277
79.81M
99.73%
-1.01M
2025Q1
2279
79.02M
98.21%
-512.23K
2024Q4
2242
76.14M
93.59%
-5.30M
2024Q3
2152
77.90M
94.66%
-4.67M
2024Q2
2140
80.09M
96.98%
-924.14K
2024Q1
2154
77.56M
93.40%
-2.57M
2023Q4
2187
77.94M
93.84%
-2.83M
2023Q3
2153
79.23M
95.34%
-677.16K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
9.93M
12.43%
+85.73K
+0.87%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
5.24M
6.56%
-65.11K
-1.23%
Sep 30, 2025
State Street Investment Management (US)
3.52M
4.41%
-36.75K
-1.03%
Sep 30, 2025
Fundsmith LLP
2.61M
3.27%
-28.83K
-1.09%
Sep 30, 2025
Geode Capital Management, L.L.C.
2.50M
3.13%
+33.39K
+1.35%
Sep 30, 2025
Baron Capital Management, Inc.
1.88M
2.36%
-148.49K
-7.31%
Sep 30, 2025
Invesco Capital Management (QQQ Trust)
1.79M
2.24%
+114.65K
+6.84%
Dec 31, 2025
Polen Capital Management, LLC
1.13M
1.41%
-68.28K
-5.71%
Sep 30, 2025
Walter Scott & Partners Ltd.
1.12M
1.4%
+360.23K
+47.61%
Sep 30, 2025
查看更多

持股ETF

更新時間: 12月2日 週二
更新時間: 12月2日 週二
機構名稱
佔比
ProShares Pet Care ETF
9.4%
iShares U.S. Medical Devices ETF
4.42%
First Trust Water ETF
3.98%
SMI 3Fourteen Full-Cycle Trend ETF
3.9%
Nuveen ESG Mid-Cap Growth ETF
3.47%
Adaptive Core ETF
2.61%
First Trust S&P 500 Economic Moat Index ETF
2.25%
Acruence Active Hedge US Equity ETF
2.18%
Tema Durable Quality ETF
2.1%
Putnam Sustainable Future ETF
2.03%
查看更多
ProShares Pet Care ETF
佔比9.4%
iShares U.S. Medical Devices ETF
佔比4.42%
First Trust Water ETF
佔比3.98%
SMI 3Fourteen Full-Cycle Trend ETF
佔比3.9%
Nuveen ESG Mid-Cap Growth ETF
佔比3.47%
Adaptive Core ETF
佔比2.61%
First Trust S&P 500 Economic Moat Index ETF
佔比2.25%
Acruence Active Hedge US Equity ETF
佔比2.18%
Tema Durable Quality ETF
佔比2.1%
Putnam Sustainable Future ETF
佔比2.03%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
KeyAI